Summary
A LUNG disease drug developed by a Liverpool professor could help thousands of patients after it gained approval for use in the UK.
Peter Calverley, Professor of Respiratory Medicine at the University of Liverpool, has led a team working on the medication for the last eight years.See the full content of this document
Extract
Lung Disease Drug Developed by City Professor Gets Go-Ahead
The drug, called Daxas, eases emphysema and chronic bronchitis and in trials re...
See the full content of this document
Sponsored links
